ATE408839T1 - Tumor marker für urothelialen krebs - Google Patents

Tumor marker für urothelialen krebs

Info

Publication number
ATE408839T1
ATE408839T1 AT03770099T AT03770099T ATE408839T1 AT E408839 T1 ATE408839 T1 AT E408839T1 AT 03770099 T AT03770099 T AT 03770099T AT 03770099 T AT03770099 T AT 03770099T AT E408839 T1 ATE408839 T1 AT E408839T1
Authority
AT
Austria
Prior art keywords
tumor marker
urothelial cancer
calreticulin protein
urothelial
cancer
Prior art date
Application number
AT03770099T
Other languages
English (en)
Inventor
Tatsuhiro Yoshiki
Susumu Kageyama
Original Assignee
Tss Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tss Biotech Inc filed Critical Tss Biotech Inc
Application granted granted Critical
Publication of ATE408839T1 publication Critical patent/ATE408839T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03770099T 2002-11-01 2003-10-31 Tumor marker für urothelialen krebs ATE408839T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002320355 2002-11-01

Publications (1)

Publication Number Publication Date
ATE408839T1 true ATE408839T1 (de) 2008-10-15

Family

ID=32211852

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03770099T ATE408839T1 (de) 2002-11-01 2003-10-31 Tumor marker für urothelialen krebs

Country Status (7)

Country Link
US (1) US7323312B2 (de)
EP (1) EP1605266B1 (de)
JP (1) JP3626177B2 (de)
AT (1) ATE408839T1 (de)
AU (1) AU2003280694A1 (de)
DE (1) DE60323685D1 (de)
WO (1) WO2004040313A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005111572A1 (ja) * 2004-05-18 2008-03-27 エーザイ・アール・アンド・ディー・マネジメント株式会社 試料調製装置及び方法
US20060072849A1 (en) * 2004-09-27 2006-04-06 Siemens Medical Solutions Usa, Inc. Multi-leaf collimator position sensing
US20090004172A1 (en) * 2006-09-08 2009-01-01 Obeid Michel Sarkis Service for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using erp57 translocation
US20090004211A1 (en) * 2006-09-08 2009-01-01 Obeid Michel Sarkis Method for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using erp57 translocation
US20090004678A1 (en) * 2006-09-08 2009-01-01 Obeid Michel Sarkis Method for screening fertility and new compounds or molecules, using crt or erp57 translocation
US20080214452A1 (en) * 2006-09-08 2008-09-04 Obeid Michel Sarkis Method for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using crt translocation
EP1900375A1 (de) * 2006-09-08 2008-03-19 Institut Gustave Roussy Verwendung von Calreticulin zur Behandlung von Krebs in Säugetiere
US20090005305A1 (en) * 2006-09-08 2009-01-01 Obeid Michel Sarkis Service for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using crt translocation
US20090004134A1 (en) * 2006-09-08 2009-01-01 Obeid Michel Sarkis Kit for treating a health condition by inducing translocation of an erp57 protein to a cellular membrane
WO2008032153A2 (en) * 2006-09-08 2008-03-20 Michel Sarkis Obeid Calreticulin for its use as a medication for the treatment of cancer in a mammal
JP2010502970A (ja) * 2006-09-08 2010-01-28 アンスティテュ・グスターブ・ルシ カルレティキュリン、ＫＤＥＬ受容体および／またはＥＲｐ５７の細胞表面露出を調節する化合物および癌の処置の効率を評価するためのその使用
US20090048159A1 (en) * 2006-09-08 2009-02-19 Obeid Michel Sarkis Kit for treating a health condition by inducing translocation of a calreticulin protein to a cellular membrane
US20090010952A1 (en) * 2006-09-08 2009-01-08 Obeid Michel Sarkis Pharmaceutical compound for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using crt or erp57 translocation
US20090004178A1 (en) * 2006-09-08 2009-01-01 Obeid Michel Sarkis Pharmaceutical compound for blocking the crt or erp57 translocation
WO2010030861A2 (en) * 2008-09-11 2010-03-18 Calretex, Llc Compositions and methods for purifying calreticulin
US8857642B2 (en) * 2010-05-05 2014-10-14 Pandol Bros., Inc. Lightweight fruit and produce packaging container
CN103265631B (zh) * 2013-05-07 2015-07-08 中国人民解放军第四军医大学 一种抗人crt单克隆抗体的重链和轻链可变区
ES2851328T3 (es) * 2014-08-20 2021-09-06 Nexans Disposición para líneas eléctricas montadas en un vehículo automóvil
JPWO2020071489A1 (ja) * 2018-10-04 2021-09-24 国立大学法人大阪大学 尿路上皮がんを検査する方法
WO2023034762A2 (en) * 2021-08-30 2023-03-09 Obi Pharma, Inc. Bispecific dendritic cell engager and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596690B2 (en) 1998-10-06 2003-07-22 The United States Of America As Represented By The Department Of Health And Human Services Vasostatin as marrow protectant
WO2000020577A1 (en) 1998-10-06 2000-04-13 The Government Of The United States Of America, Represented By The Secretary, Dept. Of Health And Huuman Services, The National Institutes Of Health Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth
US6780984B2 (en) * 2000-07-17 2004-08-24 Northwestern University Method for prognosing cancer and the proteins involved

Also Published As

Publication number Publication date
EP1605266A1 (de) 2005-12-14
JP3626177B2 (ja) 2005-03-02
DE60323685D1 (de) 2008-10-30
EP1605266A4 (de) 2005-12-21
US7323312B2 (en) 2008-01-29
EP1605266B1 (de) 2008-09-17
WO2004040313A1 (ja) 2004-05-13
AU2003280694A1 (en) 2004-05-25
US20040248217A1 (en) 2004-12-09
JPWO2004040313A1 (ja) 2006-03-02

Similar Documents

Publication Publication Date Title
DE60323685D1 (de) Tumor marker für urothelialen krebs
ATE483972T1 (de) Reagenzien und verfahren für krebsprognose und pathologische einstufung
DE602006002809D1 (de) Verfahren zur erkennung eines ovarialkarzinoms
MX2014001377A (es) Metodo para detectar cancer pancreatico.
ATE548656T1 (de) Verfahren zur identifizierung von patienten mit erhöhter wahrscheinlichkeit des auftretens eines ovarialkarzinoms und zusammensetzungen dafür
ATE513216T1 (de) Verwendung des proteins satb2 als prognostischer marker für kolorektalkarzinome
DE602005013225D1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
DK1540010T3 (da) Anvendelse af biomarkører til påvisning af ovariecancer
TW200741203A (en) Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
ATE393240T1 (de) Verfahren zum nachweis von prostatakrebs
ATE529752T1 (de) Antikörperquantifizierung
WO2006034278A3 (en) Methods and compositions for detecting cancer using components of the u2 spliceosomal particle
WO2006102526A3 (en) Identification of biomarkers by serum protein profiling
WO2010096674A3 (en) A+ biomarker assays
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
NZ701208A (en) Immuno-pet imaging of antibodies and immunoconjugates and uses thereof
JP2009539082A5 (de)
ATE462803T1 (de) Kit und verfahren zum nachweis von urothelkarzinom
MX2008000282A (es) Anticuerpos monoclonales, lineas celulares de hibridomas, metodos y kits para la deteccion de fitasa.
SG164389A1 (en) Detection of a therapeutic antibody in an experimental animal
CY1112553T1 (el) Ανοσοπροσδιορισμοι υψηλης ευαισθησιας και κιτια για τον προσδιορισμο πεπτιδιων και πρωτεϊνων βιολογικου ενδιαφεροντος
WO2007033367A3 (en) Salivary protein and rna for breast cancer detection
Rüschoff et al. A novel 5x multiplex immunohistochemical staining reveals PSMA as a helpful marker in prostate cancer with low p504s expression.
ITMI20040858A1 (it) Anticorpi monoclonali ibridomi metodo migliorato per determinare la proteina ptx3 e kit per detta determinazione

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
REN Ceased due to non-payment of the annual fee